Please login to the form below

Not currently logged in
Email:
Password:

influenza

This page shows the latest influenza news and features for those working in and with pharma, biotech and healthcare.

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus

In the past, this type of trial has been used to investigate a range of diseases, including influenza, malaria, typhoid, dengue fever and cholera.

Latest news

More from news
Approximately 16 fully matching, plus 199 partially matching documents found.

Latest Intelligence

  • Effectively communicating in a public health crisis Effectively communicating in a public health crisis

    In John M Barry’s 2009 Nature essay titled Pandemics: Avoiding the Mistakes of 1918, he said: ‘In the next influenza pandemic.

  • Biotech profile: Tom Evans, CEO, Vaccitech.

    What are the shortcomings of current influenza vaccines, and why are new products needed? ... The outcome measurement is to decrease the amount of laboratory-confirmed influenza illness.

  • Case study: Break the flu cycle Case study: Break the flu cycle

    76% of delegates felt more confident in their ability to manage the influenza vaccination. ... influenza infection, particularly among the more at-risk group of 65 years and over.

  • Deal Watch February 2016 Deal Watch February 2016

    coli and influenza, and in toxicology applications. While Abbott already has a significant diagnostics presence with global sales in 2015 in this segment of $4.6bn, it forecasts that the acquisition

  • Another lost decade for research? Another lost decade for research?

    diseases that cause significant morbidity and mortality, such as influenza and malaria, but remain difficult to vaccinate against.

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Case study

    Using qualitative conjoint to assess willingness-to-pay. Find out how we used our proprietary ChoiceQual conjoint technique to assess and develop a market access and pricing strategy for an influenza

  • Fake News is Bad for your Health

    Epidemics of measles are occurring across Europe. Rates of vaccination for influenza, HPV, tetanus and polio have also declined.

  • To track disease, follow the money

    The way that influenza spreads can be tracked by tools such as Flusurvey,(1)  which produces rapidly-updated heatmaps of illness across the country.

  • Influenza

    Agency: BASTARD. LONDON. Product: Self Promotion. Client: Self Promotion. Therapy area: Self Promotion. View the PMHub profile for: BASTARD. LONDON.

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics